CD19 or CD20 CAR T Cell Therapy Demonstrates Durable Antitumor Efficacy in Patients with Central Nervous System Lymphoma.
Liu R, Cheng Q, Kang L, Wang E, Li Y, Zhang J, Xiao H, Zhang Y, Chu L, Chen X, Zhang C, Tan J, Xu N, Li M, Yu L, Li X.
Liu R, et al. Among authors: li y, li x, li m.
Hum Gene Ther. 2022 Mar;33(5-6):318-329. doi: 10.1089/hum.2021.249.
Hum Gene Ther. 2022.
PMID: 35152726